Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Cardiovascular Disease After Cancer: What Survivors Need to Know. I was diagnosed with multiple myeloma in early 1994. I underwent several different cardiotoxic chemotherapy regimens over the next couple of years. I developed chemotherapy-induced cardiomyopathy (CIC) in 12/10, almost exactly 15 years after my autologous stem cell transplant.
I’ve since learned that CIC is a common side effect of many different cancers. The mission of PeopleBeatingCancer is to educate newly diagnosed cancer patients about long-term and late-stage side effects like CIC. This is a pillar post for CIC and cancer. While I don’t prescribe medication, I do tell people what I do to manage my many therapy-induced side effects.
While I think that oncology is more aware of cardiotoxic regimens and the damage that chemo can do to the cancer patient’s heart, I don’t think that oncology is good at managing possible long-term side effects like cardiovascular disease after cancer.
These are the therapies that I undergo daily, weekly, etc. in my efforts to stay heart-healthy.
If I had undergone the above complementary therapies during my induction therapy and autologous stem cell transplant, it’s possible that I could have prevented my CIC. I’ll never know…
The cardio-oncologist who told me that I had CIC prescribed metoprolol. I had a reaction to this medication. As a result, I don’t take any conventional heart meds for my CIC. You will have to figure that issue out for yourself.
Hang in there.
Cancer survivors are approximately 1.5–2 times more likely to develop cardiovascular disease (CVD) than the general population. Studies show that 20–30% of survivors develop heart or vascular problems within 5 years, and up to 40–60% experience cardiovascular complications long-term, especially after chemotherapy, radiation, or stem cell transplant.
Cancer and its treatments increase cardiovascular risk through:
For many survivors, beating cancer is only part of the journey.
A growing body of research shows that cardiovascular disease is one of the leading causes of illness and death among cancer survivors. In fact, for some cancers, heart disease risk may rival—or exceed—the risk of cancer recurrence over time.
This is especially true for survivors of Multiple Myeloma and other blood cancers, where intensive therapies can have lasting cardiovascular effects.
Research consistently shows elevated risk:
Cancer survivors may develop:
Many survivors assume these are “normal recovery” symptoms:
👉 These may be early signs of cardiovascular disease—not just post-treatment fatigue.
This is one of the most important—and overlooked—areas of survivorship care.
👉 Survivors should consider ongoing cardiac monitoring—even years after treatment ends.
PeopleBeatingCancer focuses on therapies that are both evidence-based and practical.
(Always discuss supplementation with your healthcare provider.)
As a long-term cancer survivor, I developed cardiovascular disease 15 years after completing treatment.
Like many survivors, I initially assumed symptoms such as fatigue and reduced endurance were simply part of recovery. Over time, it became clear that these symptoms were related to heart health—not just cancer survivorship.
This experience highlights an important reality:
👉 Survivorship care must include cardiovascular health—not just cancer surveillance.